Login / Signup

Two-year outcome of half-time photodynamic therapy for chronic central serous chorioretinopathy with and without choroidal neovascularization.

Aya KamimuraAkiko MikiMaya KishiMina OkudaMayuka Hayashida-HiranoMari SakamotoWataru MatsumiyaHisanori ImaiSentaro KusuharaMakoto Nakamura
Published in: PloS one (2023)
A htPDT for cCSC was less effective in eyes with CNV than in those without CNV regarding the recurrence and persistence of SRF. Additional treatment might be required in eyes with CNV during 24-month follow-up periods.
Keyphrases
  • optical coherence tomography
  • photodynamic therapy
  • diabetic retinopathy
  • high grade
  • vascular endothelial growth factor
  • fluorescence imaging
  • age related macular degeneration
  • combination therapy
  • drug induced